Literature DB >> 15158328

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Adnan Said1, John Williams, Jeremy Holden, Patrick Remington, Ronald Gangnon, Alexandru Musat, Michael R Lucey.   

Abstract

BACKGROUND/AIMS: The utility of the model for end stage liver disease (MELD) score in non-transplant patients, particularly in those with less severe chronic liver disease remains uncertain. We studied and compared the predictive abilities of the MELD score and the Child-Turcotte-Pugh (CTP) score for intermediate (1-year) and long-term (5-year) mortality.
METHODS: One thousand six hundred and eleven patients with chronic liver disease were studied. Observed and predicted survival curves were plotted to evaluate the predictive ability of the MELD score for survival. Receiver operating characteristic (ROC) curves was used to compare the MELD and CTP score. A multivariable model was constructed to examine predictors of mortality.
RESULTS: The MELD score was a good predictor of 1-year mortality in chronic liver disease (c-statistics for all subgroups >/=0.75) and of 3- and 6-month mortality in alcoholic hepatitis (c-statistic >/=0.83). The CTP score had similar predictive abilities as the MELD. Hepatic encephalopathy was a strong independent predictor of death (Hazard ratio-2.8, P<0.0001).
CONCLUSIONS: The MELD score is a valid prognostic score for intermediate term mortality in a heterogeneous population with chronic liver disease although the CTP score is equivalent in predicting survival. Inclusion of hepatic encephalopathy adds additional prognostic value to the MELD score.

Entities:  

Mesh:

Year:  2004        PMID: 15158328     DOI: 10.1016/j.jhep.2004.02.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  84 in total

1.  Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.

Authors:  Li-Yuan Wang; Qing-Hua Meng; Zhi-Qiang Zou; Yu-Chen Fan; Jie Han; Zhao-Xia Qi; Jian Ge; Ai-Ling Xu; Si-Kui Wang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

2.  Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.

Authors:  Pi-Qi Zhou; Shao-Ping Zheng; Min Yu; Sheng-Song He; Zhi-Hong Weng
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

3.  MELD score does not discriminate against patients with hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Kia Saeian
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

4.  Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.

Authors:  Sumita Verma; Ketan Ajudia; Michel Mendler; Allan Redeker
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

5.  Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.

Authors:  Ming Zhang; Bo Li; Lu-Nan Yan; Fei Yin; Tian-Fu Wen; Yong Zeng; Ji-Chun Zhao; Yu-Kui Ma
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.

Authors:  Eiichiro Okazaki; Akira Yamamoto; Norifumi Nishida; Masao Hamuro; Ryo Ogino; Masako Hosono; Yasuhiko Shimatani; Shinichi Tsutsumi; Shinichi Hamamoto; Etsuji Sohgawa; Atsushi Jogo; Yukio Miki
Journal:  Br J Radiol       Date:  2016-05-10       Impact factor: 3.039

7.  Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.

Authors:  Gloria L Hwang; Daniel Y Sze
Journal:  Dig Dis Sci       Date:  2017-02       Impact factor: 3.199

8.  Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection.

Authors:  Liang Huang; Jing Li; Jian-Jun Yan; Cai-Feng Liu; Meng-Chao Wu; Yi-Qun Yan
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

10.  Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Authors:  Daniel Gotthardt; Karl Heinz Weiss; Melanie Baumgärtner; Alexandra Zahn; Wolfgang Stremmel; Jan Schmidt; Thomas Bruckner; Peter Sauer
Journal:  BMC Gastroenterol       Date:  2009-09-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.